Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1990 Oct;87(19):7658–7662. doi: 10.1073/pnas.87.19.7658

Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris.

A R Ahmed 1, E J Yunis 1, K Khatri 1, R Wagner 1, G Notani 1, Z Awdeh 1, C A Alper 1
PMCID: PMC54807  PMID: 2217197

Abstract

Of 26 Ashkenazi Jewish patients with pemphigus vulgaris, 24 (92.3%) carried the major histocompatibility complex (MHC) class II alleles HLA-DR4, DQw3, of which all were of the subtype DR4, DQw8. From studies of the patients and their families, haplotypes were defined. It was found that, of the patients who carried HLA-DR4, DQw8, 75% carried one or the other (and in one case, both) of two haplotypes [HLA-B38, SC21, DR4] or HLA-B35, SC31, DR4. The former is a known extended haplotype among normal Jews, with a frequency of 0.102, and the latter may also be an extended haplotype in this ethnic group, with a frequency of 0.017 among normal haplotypes from Jews. Of the remaining DR4-positive patients, all but one had a presumed D-region segment (defined as SC21, DR4, DQw8 or SC31, DR4, DQw8 with variable HLA-B) of these haplotypes. Only one patient had DR4, DQw8 without any other markers of the extended haplotypes. The number of homozygotes and heterozygotes for DR4, DQw8 was consistent with dominant but not recessive (P less than 0.01) inheritance of a class II or a class II-linked susceptibility gene for the disease. Since the disease is entirely attributable to the presence of an antibody to an intraepidermal intercellular cement substance, it is likely that the class II susceptibility gene (on [HLA-B38, SC21, DR4, DQw8], HLA-B35, SC31, DR4, DQw8, or their segments, in Jewish patients) controls the production of the antibody as a dominantly expressed immune response gene.

Full text

PDF
7658

Images in this article

7660Image
on p.7660
7661Image
on p.7661

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed A. R., Park M. S., Tiwari J. L., Terasaki P. I. Association of DR4 with pemphigus. Exp Clin Immunogenet. 1987;4(1):8–16. [PubMed] [Google Scholar]
  2. Ahmed A. R., Workman S. Anti-intercellular substance antibodies. Presence in serum samples of 14 patients without pemphigus. Arch Dermatol. 1983 Jan;119(1):17–21. doi: 10.1001/archderm.119.1.17. [DOI] [PubMed] [Google Scholar]
  3. Ahmed A. R., Yunis E. J., Alper C. A. Complotypes in pemphigus vulgaris: differences between Jewish and non-Jewish patients. Hum Immunol. 1990 Apr;27(4):298–304. doi: 10.1016/0198-8859(90)90081-y. [DOI] [PubMed] [Google Scholar]
  4. Alper C. A., Awdeh Z. L., Raum D. D., Yunis E. J. Extended major histocompatibility complex haplotypes in man: role of alleles analogous to murine t mutants. Clin Immunol Immunopathol. 1982 Aug;24(2):276–285. doi: 10.1016/0090-1229(82)90238-0. [DOI] [PubMed] [Google Scholar]
  5. Alper C. A., Boenisch T., Watson L. Genetic polymorphism in human glycine-rich beta-glycoprotein. J Exp Med. 1972 Jan;135(1):68–80. doi: 10.1084/jem.135.1.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Alper C. A., Fleischnick E., Awdeh Z., Katz A. J., Yunis E. J. Extended major histocompatibility complex haplotypes in patients with gluten-sensitive enteropathy. J Clin Invest. 1987 Jan;79(1):251–256. doi: 10.1172/JCI112791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Alper C. A. Inherited structural polymorphism in human C2: evidence for genetic linkage between C2 and Bf. J Exp Med. 1976 Oct 1;144(4):1111–1115. doi: 10.1084/jem.144.4.1111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Alper C. A., Kruskall M. S., Marcus-Bagley D., Craven D. E., Katz A. J., Brink S. J., Dienstag J. L., Awdeh Z., Yunis E. J. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med. 1989 Sep 14;321(11):708–712. doi: 10.1056/NEJM198909143211103. [DOI] [PubMed] [Google Scholar]
  9. Alper C. A., Raum D., Karp S., Awdeh Z. L., Yunis E. J. Serum complement 'supergenes' of the major histocompatibility complex in man (complotypes). Vox Sang. 1983;45(1):62–67. doi: 10.1111/j.1423-0410.1983.tb04124.x. [DOI] [PubMed] [Google Scholar]
  10. Anhalt G. J., Labib R. S., Voorhees J. J., Beals T. F., Diaz L. A. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med. 1982 May 20;306(20):1189–1196. doi: 10.1056/NEJM198205203062001. [DOI] [PubMed] [Google Scholar]
  11. Awdeh Z. L., Alper C. A., Eynon E., Alosco S. M., Stein R., Yunis E. J. Unrelated individuals matched for MHC extended haplotypes and HLA-identical siblings show comparable responses in mixed lymphocyte culture. Lancet. 1985 Oct 19;2(8460):853–856. doi: 10.1016/s0140-6736(85)90123-0. [DOI] [PubMed] [Google Scholar]
  12. Awdeh Z. L., Alper C. A. Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci U S A. 1980 Jun;77(6):3576–3580. doi: 10.1073/pnas.77.6.3576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Awdeh Z. L., Raum D., Yunis E. J., Alper C. A. Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man. Proc Natl Acad Sci U S A. 1983 Jan;80(1):259–263. doi: 10.1073/pnas.80.1.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Bell J. I., Denny D. W., Jr, McDevitt H. O. Structure and polymorphism of murine and human class II major histocompatibility antigens. Immunol Rev. 1985 Jul;84:51–71. doi: 10.1111/j.1600-065x.1985.tb01125.x. [DOI] [PubMed] [Google Scholar]
  15. Benacerraf B., McDevitt H. O. Histocompatibility-linked immune response genes. Science. 1972 Jan 21;175(4019):273–279. doi: 10.1126/science.175.4019.273. [DOI] [PubMed] [Google Scholar]
  16. Brautbar C., Moscovitz M., Livshits T., Haim S., Hacham-Zadeh S., Cohen H. A., Sharon R., Nelken D., Cohen T. HLA-DRw4 in pemphigus vulgaris patients in Israel. Tissue Antigens. 1980 Sep;16(3):238–243. doi: 10.1111/j.1399-0039.1980.tb00299.x. [DOI] [PubMed] [Google Scholar]
  17. Bugawan T. L., Horn G. T., Long C. M., Mickelson E., Hansen J. A., Ferrara G. B., Angelini G., Erlich H. A. Analysis of HLA-DP allelic sequence polymorphism using the in vitro enzymatic DNA amplification of DP-alpha and DP-beta loci. J Immunol. 1988 Dec 1;141(11):4024–4030. [PubMed] [Google Scholar]
  18. Chan S. H., Tan T. HLA and pemphigus in Chinese. Dermatologica. 1981;163(2):205–206. doi: 10.1159/000250162. [DOI] [PubMed] [Google Scholar]
  19. Dasgupta J. D., Relias V., Awdeh Z. L., Alper C. A., Yunis E. J. Two variants of DRw52, DR3, and DQw2 specificities distinguish two different DR3-bearing extended haplotypes. Hum Immunol. 1988 Feb;21(2):133–142. doi: 10.1016/0198-8859(88)90088-2. [DOI] [PubMed] [Google Scholar]
  20. Fleischnick E., Awdeh Z. L., Raum D., Granados J., Alosco S. M., Crigler J. F., Jr, Gerald P. S., Giles C. M., Yunis E. J., Alper C. A. Extended MHC haplotypes in 21-hydroxylase-deficiency congenital adrenal hyperplasia: shared genotypes in unrelated patients. Lancet. 1983 Jan 22;1(8317):152–156. doi: 10.1016/s0140-6736(83)92757-5. [DOI] [PubMed] [Google Scholar]
  21. Korman A. J., Boss J. M., Spies T., Sorrentino R., Okada K., Strominger J. L. Genetic complexity and expression of human class II histocompatibility antigens. Immunol Rev. 1985 Jul;85:45–86. doi: 10.1111/j.1600-065x.1985.tb01130.x. [DOI] [PubMed] [Google Scholar]
  22. Korman N. Pemphigus. J Am Acad Dermatol. 1988 Jun;18(6):1219–1238. doi: 10.1016/s0190-9622(88)70128-0. [DOI] [PubMed] [Google Scholar]
  23. Krain L. S., Terasaki P. I., Newcomer V. D., Mickey M. R. Increased frequency of HL-A10 in pemphigus vulgaris. Arch Dermatol. 1973 Dec;108(6):803–805. [PubMed] [Google Scholar]
  24. Kruskall M. S., Eynon E. E., Awdeh Z., Alper C. A., Yunis E. J. Identification of HLA-B44 subtypes associated with extended MHC haplotypes. Immunogenetics. 1987;26(4-5):216–219. doi: 10.1007/BF00346515. [DOI] [PubMed] [Google Scholar]
  25. Park M. S., Terasaki P. I., Ahmed A. R., Tiwari J. L. HLA-DRW4 in 91% of Jewish pemphigus vulgaris patients. Lancet. 1979 Sep 1;2(8140):441–442. doi: 10.1016/s0140-6736(79)91493-4. [DOI] [PubMed] [Google Scholar]
  26. Raum D., Awdeh Z., Yunis E. J., Alper C. A., Gabbay K. H. Extended major histocompatibility complex haplotypes in type I diabetes mellitus. J Clin Invest. 1984 Aug;74(2):449–454. doi: 10.1172/JCI111441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Scharf S. J., Friedmann A., Brautbar C., Szafer F., Steinman L., Horn G., Gyllensten U., Erlich H. A. HLA class II allelic variation and susceptibility to pemphigus vulgaris. Proc Natl Acad Sci U S A. 1988 May;85(10):3504–3508. doi: 10.1073/pnas.85.10.3504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Szafer F., Brautbar C., Tzfoni E., Frankel G., Sherman L., Cohen I., Hacham-Zadeh S., Aberer W., Tappeiner G., Holubar K. Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQw1 and DQw3 alleles of the HLA-D region. Proc Natl Acad Sci U S A. 1987 Sep;84(18):6542–6545. doi: 10.1073/pnas.84.18.6542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Todd J. A., Acha-Orbea H., Bell J. I., Chao N., Fronek Z., Jacob C. O., McDermott M., Sinha A. A., Timmerman L., Steinman L. A molecular basis for MHC class II--associated autoimmunity. Science. 1988 May 20;240(4855):1003–1009. doi: 10.1126/science.3368786. [DOI] [PubMed] [Google Scholar]
  30. Wasserstrum N., Laros R. K., Jr Transplacental transmission of pemphigus. JAMA. 1983 Mar 18;249(11):1480–1482. [PubMed] [Google Scholar]
  31. Wescott M. Z., Awdeh Z. L., Yunis E. J., Alper C. A. Molecular analysis distinguishes two HLA-DR3-bearing major histocompatibility complex extended haplotypes. Immunogenetics. 1987;26(6):370–374. doi: 10.1007/BF00343707. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES